Clinical Trial Update: An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia [Phase 1]

View source ↗

Summary

Open-label Phase 1 study comparing the bioavailability of TV-44749 to oral olanzapine in participants with schizophrenia; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• TV-44749
• olanzapine (olanzapine)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED